The main objective of the MELINA project is to develop an artificial intelligence (AI) platform applied to nanomedicine in order to accelerate the design and development of new nanomedicines. In particular, it focuses on the use of artificial intelligence and machine learning (ML) to improve the synthesis, characterisation and biological evaluation of therapeutic nanoparticles, especially in the field of cancer treatment.